Exact Mass: 554.372

Ganoderic acid Me

(e)-6-(3,15-Diacetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1h-cyclopenta[a]phenanthren-17-yl)-2-methylhept-2-enoic acid

Ganodermic acid S is found in mushrooms. Ganodermic acid S is a metabolite of Ganoderma lucidum (reishi). Metabolite of Ganoderma lucidum (reishi). Ganoderic acid Me is found in mushrooms.

Ganoderic acid R

(E)-5-Acetyloxy-6-(3-acetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methylhept-2-enoic acid

Ganoderic acid R is found in mushrooms. Ganoderic acid R is a constituent of cultured mycelium of Ganoderma lucidum (reishi) Constituent of cultured mycelium of Ganoderma lucidum (reishi). Ganoderic acid R is found in mushrooms.

Notoginsenoside R10

1-(5,16-dihydroxy-2,6,6,10,11-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl)ethan-1-one

Notoginsenoside R10 is found in tea. Notoginsenoside R10 is a constituent of Panax notoginseng (sanchi) roots. Constituent of Panax notoginseng (sanchi) roots. Notoginsenoside R10 is found in tea.

(2xi,3xi)-2,3-Dihydroxy-12,18-ursadien-28-oic acid diacetate

10,11-bis(acetyloxy)-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13-octadecahydropicene-4a-carboxylic acid

(2xi,3xi)-2,3-Dihydroxy-12,18-ursadien-28-oic acid diacetate is found in pomes. (2xi,3xi)-2,3-Dihydroxy-12,18-ursadien-28-oic acid diacetate is a constituent of Pyrus communis (pear). Constituent of Pyrus communis (pear). (2xi,3xi)-2,3-Dihydroxy-12,18-ursadien-28-oic acid diacetate is found in pomes.

Epoxomicin

(2S,3S)-N-((2S,3R)-3-Hydroxy-1-(N-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)acetamido)-1-oxobutan-2-yl)-3-methyl-2-((2S,3S)-3-methyl-2-(methylamino)pentanamido)pentanamide

C28H50N4O7 (554.3679)

DG(10:0/5-iso PGF2VI/0:0)

(2S)-2-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-hydroxypropyl decanoate

DG(10:0/5-iso PGF2VI/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/5-iso PGF2VI/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(5-iso PGF2VI/10:0/0:0)

(2S)-1-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-hydroxypropan-2-yl decanoic acid

DG(5-iso PGF2VI/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(5-iso PGF2VI/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/5-iso PGF2VI)

(2R)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-hydroxypropyl decanoic acid

DG(10:0/0:0/5-iso PGF2VI) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(5-iso PGF2VI/0:0/10:0)

(2S)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-hydroxypropyl decanoic acid

DG(5-iso PGF2VI/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/PGF2alpha/0:0)

(2S)-2-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-3-hydroxypropyl octanoic acid

DG(8:0/PGF2alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/PGF2alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGF2alpha/8:0/0:0)

(2S)-1-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-3-hydroxypropan-2-yl octanoic acid

DG(PGF2alpha/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGF2alpha/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/PGF2alpha)

(2R)-3-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-2-hydroxypropyl octanoic acid

DG(8:0/0:0/PGF2alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGF2alpha/0:0/8:0)

(2S)-3-{[(5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoyl]oxy}-2-hydroxypropyl octanoic acid

DG(PGF2alpha/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/PGE1/0:0)

(2S)-3-Hydroxy-2-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)propyl octanoic acid

DG(8:0/PGE1/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/PGE1/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE1/8:0/0:0)

(2S)-1-Hydroxy-3-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)propan-2-yl octanoic acid

DG(PGE1/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE1/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/PGE1)

(2R)-2-Hydroxy-3-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)propyl octanoic acid

DG(8:0/0:0/PGE1) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE1/0:0/8:0)

(2S)-2-Hydroxy-3-({7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoyl}oxy)propyl octanoic acid

DG(PGE1/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/PGD1/0:0)

(2S)-3-Hydroxy-2-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)propyl octanoic acid

DG(8:0/PGD1/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/PGD1/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD1/8:0/0:0)

(2S)-1-Hydroxy-3-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)propan-2-yl octanoic acid

DG(PGD1/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD1/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/PGD1)

(2R)-2-Hydroxy-3-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)propyl octanoic acid

DG(8:0/0:0/PGD1) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD1/0:0/8:0)

(2S)-2-Hydroxy-3-({7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoyl}oxy)propyl octanoic acid

DG(PGD1/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

(1S)-1,2,3,4-Tetrahydromanzamine B

C36H50N4O (554.3984)

Stypotriol triacetate

Muscanone

5,7,4-Trihydroxy-3-O- (1,8,14-trimethylhexadecanyl) flavanone

Ganodermic acid S

(e)-6-(3,15-Diacetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1h-cyclopenta[a]phenanthren-17-yl)-2-methylhept-2-enoic acid

(13Z,15E,17E)-3beta,28-diacetoxy-22-hydroxymalabarica-13,15,17,24-tetraen-12-one

Sapelenin C

C32H58O7 (554.4182)

16,17-dihydro-homobatrachotoxin|3,9-epoxy-20alphaF-(2-ethyl-4-methyl-pyrrole-3-carbonyloxy)-25-methyl-(5beta,17xiH)-14beta,13-[1]oxa[4]azapentano-18-nor-pregn-7-en-3beta,11alpha-diol|Homobatrachotoxin|O20-(2-ethyl-4-methyl-pyrrole-3-carbonyl)-16,17-dihydro-batrachotoxinin-A

16,17-dihydro-homobatrachotoxin|3,9-epoxy-20alphaF-(2-ethyl-4-methyl-pyrrole-3-carbonyloxy)-25-methyl-(5beta,17xiH)-14beta,13-[1]oxa[4]azapentano-18-nor-pregn-7-en-3beta,11alpha-diol|Homobatrachotoxin|O20-(2-ethyl-4-methyl-pyrrole-3-carbonyl)-16,17-dihydro-batrachotoxinin-A

C32H46N2O6 (554.3356)

22-Angeloyl-(3beta,22beta)-3,22-Dihydroxy-12-oleanen-28-oic acid

acacic acid lactone diacetate

4-(2,2-dimethyl-3-oxo-cyclopropan-1-yl)-2,3-dihydrowithaferin A

BDBM50370717

C28H50N4O7 (554.3679)

C30H50O9

ingenol 3-O-(2E,4Z)-tetradecadienoate

manzamine H

C36H50N4O (554.3984)

(22S,24S)-2-acetoxy-16,24-anhydro-22,25-anhydro-16alpha,22,24,25-tetrahydroxy-22-methoxy-3,11-dioxo-cucurbita-1,5-diene

NSC626775

3-alpha-tigloylmelianol

holosta-7,24-diene-3beta,16beta-diol diacetate

1-O-(24-deoxycholyl)-beta-D-galactopyranose

3-acetyl-perenniporiol

17-tert-butoxy-19-tert-butyl-9-hydroxy-19-methyl-2-oxo-corynox-16-ene-16-carboxylic acid tert-butyl ester|Speciofolin

C33H50N2O5 (554.372)

12beta-acetoxyperenniporiol

caloverticillic acid C

Spheroidinon

C39H54O2 (554.4124)

Leu Ala Pro Lys Ile

C27H50N6O6 (554.3792)

[3-hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate

NCGC00168955-03![3-hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate

[3-hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate [IIN-based on: CCMSLIB00000847525]

NCGC00168955-03![3-hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate [IIN-based on: CCMSLIB00000847525]

[3-hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate [IIN-based: Match]

NCGC00168955-03![3-hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate [IIN-based: Match]

VNLPI

Val Asn Leu Pro Ile

C26H46N6O7 (554.3428)

PG(21:0/0:0)

1-heneicosanoyl-glycero-3-phospho-(1-sn-glycerol)

Ganoderic acid Me

(2E)-6-[5,12-bis(acetyloxy)-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1(17),9-dien-14-yl]-2-methylhept-2-enoic acid

Ganoderic acid R

(2E)-5-(acetyloxy)-6-[5-(acetyloxy)-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1(17),9-dien-14-yl]-2-methylhept-2-enoic acid

(2xi,3xi)-2,3-Dihydroxy-12,18-ursadien-28-oic acid diacetate

10,11-bis(acetyloxy)-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13-octadecahydropicene-4a-carboxylic acid

Notoginsenoside R10

1-(5,16-dihydroxy-2,6,6,10,11-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl)ethan-1-one

LPG 21:0

1-heneicosanoyl-glycero-3-phospho-(1-sn-glycerol)

Triacontyltrichlorosilane

C30H61Cl3Si (554.3608)

Epoxomicin

C28H50N4O7 (554.3679)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061988 - Proteasome Inhibitors

RTA-408

Omaveloxolone

C33H44F2N2O3 (554.332)

C26170 - Protective Agent > C2459 - Chemoprotective Agent > C2080 - Cytoprotective Agent

beta-D-galactosyl-deoxycholate

beta-D-galactosyl-chenodeoxycholate

DG(8:0/PGF2alpha/0:0)

DG(PGF2alpha/8:0/0:0)

DG(8:0/0:0/PGF2alpha)

DG(PGF2alpha/0:0/8:0)

DG(8:0/PGE1/0:0)

DG(PGE1/8:0/0:0)

DG(8:0/0:0/PGE1)

DG(PGE1/0:0/8:0)

DG(8:0/PGD1/0:0)

DG(PGD1/8:0/0:0)

DG(8:0/0:0/PGD1)

DG(PGD1/0:0/8:0)

DG(10:0/5-iso PGF2VI/0:0)

DG(5-iso PGF2VI/10:0/0:0)

DG(10:0/0:0/5-iso PGF2VI)

DG(5-iso PGF2VI/0:0/10:0)

3alpha-Glc-CDCA

[3-Hydroxy-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)decan-5-yl] 3,5-dihydroxydecanoate

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea

1-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-fluorophenyl)urea

6,8a-Seco-6,8a-deoxy-5-oxoavermectin1b aglycone

NAGlySer 13:1/12:0

NAGlySer 10:0/15:1

NAGlySer 15:1/10:0

NAGlySer 12:0/13:1

NAGlySer 14:1/11:0

NAGlySer 11:0/14:1

2,3-Dihydroxypropyl (3-docosoxy-2-hydroxypropyl) hydrogen phosphate

C28H59O8P (554.3947)

[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] henicosanoate

Mgdg O-16:4_5:0

Mgdg O-18:4_3:0

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] decanoate

[1-Decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] undecanoate

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C29H51N2O6P (554.3485)

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-undecanoyloxypropoxy]propyl]-trimethylazanium

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropyl] (4E,7E)-hexadeca-4,7-dienoate

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-undecanoyloxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropyl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

[3-[3-butanoyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

[1-carboxy-3-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium

[3-[3-acetyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

2-[[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO6P+ (554.361)

1-heneicosanoyl-glycero-3-phospho-(1-sn-glycerol)

PA(27:5)

PA(16:1(1)_11:4)

C30H51O7P (554.3372)

NA-Orn 28:7

C33H50N2O5 (554.372)

MGDG O-21:4

MGMG 21:4

LPG O-22:0

C28H59O8P (554.3947)

LPEth 25:5

C30H51O7P (554.3372)

LPM 26:5

C30H51O7P (554.3372)

ST 24:0;O3;GlcA

ST 27:5;O;GlcA

ST 24:1;O4;Hex

ST 25:0;O3;Hex

ST 27:6;O2;Hex

ST 28:5;O;Hex

DCAE 11:3

2,2,6a,6b,9,9,12a-heptamethyl-4-[(2-methylbutanoyl)oxy]-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid

9-hydroxy-5a,5b,8,8,11a-pentamethyl-6-[(3-methylbut-2-enoyl)oxy]-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

methyl 3-[(2r,3r)-5-methoxy-2,3-dimethyl-6-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-6-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-8-yl]hexanoate

(3e,5z,7r,8s,9s,11z,13z,15s,16r)-16-[(2s,3e)-4-[(6r)-6-ethyl-5-methyl-6h-pyran-2-yl]pent-3-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

2,3,6,22,23-pentahydroxy-2,6,10,15,19,23-hexamethyltetracosa-10,14,18-trien-7-yl acetate

C32H58O7 (554.4182)

2,3,6,10,11-pentahydroxy-2,6,10,15,19,23-hexamethyltetracosa-14,18,22-trien-7-yl acetate

C32H58O7 (554.4182)

4,5-bis(acetyloxy)-2',4'b,7,8',8',10'a-hexamethyl-2',3',4',4'a,5',6',7',8'a,9',10'-decahydro-3h-spiro[1-benzofuran-2,1'-phenanthren]-7'-yl acetate

(2e)-6-[3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

ethyl 3-[(1s,4r,5r,7s,8s,9r,12s,13r)-7-(acetyloxy)-4,8-dimethyl-5-[(1s)-1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-12-(prop-1-en-2-yl)tetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradecan-13-yl]propanoate

ethyl 3-[(1s,4r,5r,7s,8s,9r,12s,13r)-7-(acetyloxy)-4,8-dimethyl-5-[(1s)-1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-12-(prop-1-en-2-yl)tetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradecan-13-yl]propanoate

(1r,2r,8z,12r,13s,21e,26s,27s)-27-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]-25-oxa-3,16-diazapentacyclo[11.11.3.1¹²,¹⁶.0¹,²⁶.0²,¹²]octacosa-8,21-diene

C36H50N4O (554.3984)

2,3-dihydroxy-5,12-oleanadien-28-oic acid; (2β,3α)-form,di-ac

{"Ingredient_id": "HBIN004049","Ingredient_name": "2,3-dihydroxy-5,12-oleanadien-28-oic acid; (2\u03b2,3\u03b1)-form,di-ac","Alias": "NA","Ingredient_formula": "C34H50O6","Ingredient_Smile": "NA","Ingredient_weight": "554.76","OB_score": "NA","CAS_id": "142293-75-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8936","PubChem_id": "NA","DrugBank_id": "NA"}

methyl 3-[(2r,3r)-5-methoxy-2,3-dimethyl-6-[5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-6-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-8-yl]hexanoate

3-butyl-6-[(2r,3s,4e,7e,10e,12e,15r,16r,17s,18e)-3,15,17-trihydroxy-4,8,10,12,16,18-hexamethylicosa-4,7,10,12,18-pentaen-2-yl]pyran-2-one

(2e,6r)-6-[(1r,3s,3ar,5ar,7r,9as,11ar)-3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

16-[4-(6-ethyl-5-methyl-6h-pyran-2-yl)pent-3-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

(2e,5s,6s)-6-[(1r,3ar,5ar,7s,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-methylhept-2-enoic acid

3-[(9,15-dimethylheptadecan-2-yl)oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one

(2r)-2-[(1r,3s,3ar,5ar,7s,9as,11ar)-3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoic acid

3-butyl-6-[(3s,4e,7e,10e,12e,15r,16r,17s,18e)-3,15,17-trihydroxy-4,8,10,12,16,18-hexamethylicosa-4,7,10,12,18-pentaen-2-yl]pyran-2-one

(2s,3r)-3-{[(2s,9r,15s)-9,15-dimethylheptadecan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one

methyl 3-[(2r,3r)-6-{[2,2-dimethyl-3-(prop-1-en-2-yl)cyclobutyl]methyl}-5-methoxy-2,3-dimethyl-6-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-8-yl]hexanoate

(4e)-6-hydroxy-4-[(2e,4r,6e)-8-[(2r,4s,6r)-4-hydroxy-6-methyl-6-{[(3r,4s)-4-methylheptan-3-yl]oxy}oxan-2-yl]-4,6-dimethylocta-2,6-dien-1-ylidene]-7-methyl-3h-2-benzopyran-1-one

(2z,6r)-6-[(1r,3s,3ar,5ar,7r,9as,11ar)-3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

10-[7-(acetyloxy)-6-(hydroxymethyl)-3a,6,9a-trimethyl-2-oxo-octahydrocyclopenta[a]naphthalen-3-ylidene]-2,6-dimethylundeca-2,6,8-trien-5-yl acetate

(2e,5s,6s)-6-[(1r,3ar,5ar,7r,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-methylhept-2-enoic acid

6-[3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

(2e,6s)-6-[(1r,3s,3ar,5ar,7s,9as,11ar)-3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

(5s,6e,8e)-10-[(3z,3as,5ar,6s,7s,9ar,9bs)-7-(acetyloxy)-6-(hydroxymethyl)-3a,6,9a-trimethyl-2-oxo-octahydrocyclopenta[a]naphthalen-3-ylidene]-2,6-dimethylundeca-2,6,8-trien-5-yl acetate

(1r,3s,3ar,5ar,7s,9as,11r,11as)-11-acetyl-7-hydroxy-1-[(1s)-1-[(2s,6s)-6-hydroxy-5-methyl-3,6-dihydro-2h-pyran-2-yl]ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-3-yl acetate

(1r,3s,3ar,5ar,7s,9as,11r,11as)-11-acetyl-7-hydroxy-1-[(1s)-1-[(2s,6s)-6-hydroxy-5-methyl-3,6-dihydro-2h-pyran-2-yl]ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-3-yl acetate

[(3z,3as,5as,6s,7r,9as,9bs)-7-(acetyloxy)-3-[(3e,5e,7r)-7-hydroxy-6,10-dimethylundeca-3,5,9-trien-2-ylidene]-3a,6,9a-trimethyl-2-oxo-octahydrocyclopenta[a]naphthalen-6-yl]methyl acetate

(2s,3r)-3-{[(2s,9r,15r)-9,15-dimethylheptadecan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one

3-(8-{[2,2-dimethyl-3-(prop-1-en-2-yl)cyclobutyl]methyl}-5-hydroxy-2,3-dimethyl-8-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-6-yl)octanoic acid

(2e,6r)-6-[(1r,3r,3ar,5ar,7r,9as,11ar)-3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

7-(acetyloxy)-1-[1-(6-hydroxy-5-methyl-3,6-dihydro-2h-pyran-2-yl)ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-3-yl acetate

3-(6-{[2,2-dimethyl-3-(prop-1-en-2-yl)cyclobutyl]methyl}-5-hydroxy-2,3-dimethyl-6-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-8-yl)octanoic acid

(1s,2r,6s,7s,9r,11s,12s,15r,16s)-6-[(1r)-2,2-dimethyl-3-oxocyclopropoxy]-15-[(1s)-1-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-3-one

(1s,2r,6s,7s,9r,11s,12s,15r,16s)-6-[(1r)-2,2-dimethyl-3-oxocyclopropoxy]-15-[(1s)-1-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-3-one

1-[(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

(2e,6r)-6-[(1r,3s,3ar,7s,9as,11ar)-3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

(5s)-10-[(3z,3as,5ar,6s,7s,9ar,9bs)-7-(acetyloxy)-6-(hydroxymethyl)-3a,6,9a-trimethyl-2-oxo-octahydrocyclopenta[a]naphthalen-3-ylidene]-2,6-dimethylundeca-2,6,8-trien-5-yl acetate

(5s,6e,8e)-10-[(3z,3as,5ar,6s,7r,9ar,9bs)-7-(acetyloxy)-6-(hydroxymethyl)-3a,6,9a-trimethyl-2-oxo-octahydrocyclopenta[a]naphthalen-3-ylidene]-2,6-dimethylundeca-2,6,8-trien-5-yl acetate

(4r,4as,6as,6br,12ar,12br,14br)-2,2,6a,6b,9,9,12a-heptamethyl-4-{[(2s)-2-methylbutanoyl]oxy}-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid

(2r)-2-[(1r,3r,3ar,7s,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-3-(2-oxopropyl)-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoic acid

6-(2,2-dimethyl-3-oxocyclopropoxy)-15-{1-[5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl}-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-3-one

(2z,6r)-6-[(1r,3s,3ar,5ar,7s,9as,11ar)-3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

2-[7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-3-(2-oxopropyl)-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoic acid

ethyl 3-[7-(acetyloxy)-4,8-dimethyl-5-[1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-12-(prop-1-en-2-yl)tetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradecan-13-yl]propanoate

(4r,4as,6as,6br,8ar,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-4-{[(2s)-2-methylbutanoyl]oxy}-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid

(2e,5s,6s)-6-[(1r,3ar,7r,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-methylhept-2-enoic acid

(1r,3as,5ar,5br,6s,7ar,9r,11as,11br,13ar,13br)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-6-[(3-methylbut-2-enoyl)oxy]-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2r,3s,5s)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl (2e)-2-methylbut-2-enoate

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2r,3s,5s)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl (2e)-2-methylbut-2-enoate

(4r,4as,6as,6br,8ar,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-4-{[(2r)-2-methylbutanoyl]oxy}-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid

(2s,2's,4'ar,4'bs,7's,8'ar,10'ar)-4,5-bis(acetyloxy)-2',4'b,7,8',8',10'a-hexamethyl-2',3',4',4'a,5',6',7',8'a,9',10'-decahydro-3h-spiro[1-benzofuran-2,1'-phenanthren]-7'-yl acetate

(2e,5s,6r)-6-[(1r,3ar,5ar,7s,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-methylhept-2-enoic acid

methyl 3-{5-methoxy-2,3-dimethyl-6-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-6-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-8-yl}hexanoate

(1r,3s,3ar,5ar,7s,9as,11ar)-7-(acetyloxy)-1-[(1s)-1-[(2s,6s)-6-hydroxy-5-methyl-3,6-dihydro-2h-pyran-2-yl]ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-3-yl acetate

(1r,3s,3ar,5ar,7s,9as,11ar)-7-(acetyloxy)-1-[(1s)-1-[(2s,6s)-6-hydroxy-5-methyl-3,6-dihydro-2h-pyran-2-yl]ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-3-yl acetate